Matthew Sykes
Stock Analyst at Goldman Sachs
(0.97)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
FTRE Fortrea Holdings | Maintains: Neutral | 7 5 | 5.31 | -5.84% | 4 | May 14, 2025 | |
CTKB Cytek Biosciences | Maintains: Sell | 4 3 | 3.23 | -7.12% | 9 | May 12, 2025 | |
TXG 10x Genomics | Maintains: Sell | 8 7 | 10.88 | -40.26% | 7 | May 12, 2025 | |
BRKR Bruker | Maintains: Neutral | 50 45 | 39.66 | 13.46% | 5 | May 8, 2025 | |
MYGN Myriad Genetics | Maintains: Buy | 14 8 | 5.05 | 58.42% | 12 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 48 | 35.84 | 33.93% | 10 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 14 17 | 11.26 | 50.98% | 1 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 180 160 | 148.46 | 7.77% | 4 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 10 | 7.21 | 38.7% | 8 | Apr 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 140 125 | 96.36 | 29.72% | 2 | Apr 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 23 14 | 13.46 | 4.01% | 6 | Apr 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 260 240 | 197.51 | 21.51% | 5 | Apr 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 26 | 18.91 | 37.49% | 10 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 190 170 | 148.58 | 14.42% | 4 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 49 56 | 49.98 | 12.04% | 13 | Feb 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 70 80 | 91.22 | -12.3% | 11 | Feb 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | 1.2 | 25% | 5 | Feb 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 160 190 | 171.99 | 10.47% | 13 | Jan 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 3 2 | 0.71 | 146.48% | 5 | Dec 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 7 5 | 2.23 | 90.58% | 10 | Dec 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 38 37 | 26.87 | 37.7% | 5 | Dec 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 75 65 | 51.15 | 27.08% | 12 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 280 250 | 158.6 | 57.63% | 2 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 23 7 | n/a | n/a | 11 | Jul 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 24 | 5.88 | 308.16% | 13 | Jul 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1150 1300 | 1186.52 | 9.56% | 5 | Jul 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 32 12 | 9.14 | 31.29% | 6 | Jul 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 550 640 | 404.13 | 58.36% | 4 | Apr 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 128 145 | 117.75 | 23.14% | 4 | Dec 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 3 | Dec 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 1 | n/a | n/a | 6 | Nov 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 1 1 | n/a | n/a | 8 | Oct 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 1 | n/a | n/a | 2 | May 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 16 18 | n/a | n/a | 5 | Feb 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 3 1 | n/a | n/a | 2 | Dec 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 200 175 | n/a | n/a | 3 | Jul 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 120 60 | n/a | n/a | 4 | Apr 19, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | n/a | n/a | 4 | Apr 13, 2022 |